Nextech Crossover I GP S.a. r.l. 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-24 4:15 pm Purchase | 2024-05-06 | 13G | Context Therapeutics Inc. CNTX | Nextech Crossover I GP S.a. r.l. | 7,419,355 9.900% | 7,419,355 (New Position) | Filing |